Return to search

Towards personalised therapy in oesophageal adenocarcinoma (from the LEO trial to the identification of SIRT2 as an inflammatory modulator)

No description available.
Identiferoai:union.ndltd.org:bl.uk/oai:ethos.bl.uk:708266
Date January 2014
CreatorsSchulz, Laura Katharina Elisabeth
PublisherUniversity of Cambridge
Source SetsEthos UK
Detected LanguageEnglish
TypeElectronic Thesis or Dissertation

Page generated in 0.0023 seconds